US Patent

US8642079 — Solid formulations of ospemifene

Formulation · Assigned to Hormos Medical Corp · Expires 2028-07-09 · 2y remaining

Vulnerability score 60/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects solid formulations of ospemifene, specifically granulates containing the active compound and intra-granular excipients.

USPTO Abstract

This invention relates to a solid drug formulation comprising granulates containing a therapeutically active compound of the formula (I) or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof, in combination with one or more intra-granular excipients.

Drugs covered by this patent

Patent Metadata

Patent number
US8642079
Jurisdiction
US
Classification
Formulation
Expires
2028-07-09
Drug substance claim
No
Drug product claim
Yes
Assignee
Hormos Medical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.